Drug Shortage Report for TEVA-RABEPRAZOLE EC
Report ID | 106939 |
Drug Identification Number | 02296632 |
Brand name | TEVA-RABEPRAZOLE EC |
Common or Proper name | RABEPRAZOLE 10MG TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | RABEPRAZOLE SODIUM |
Strength(s) | 10MG |
Dosage form(s) | TABLET (DELAYED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2020-02-20 |
Estimated end date | |
Actual end date | 2020-03-25 |
Shortage status | Resolved |
Updated date | 2020-07-10 |
Company comments | Item is discontinued. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-02-21 | English | Compare |
v2 | 2020-02-21 | French | Compare |
v3 | 2020-03-05 | English | Compare |
v4 | 2020-03-05 | French | Compare |
v5 | 2020-03-06 | English | Compare |
v6 | 2020-03-06 | French | Compare |
v7 | 2020-07-10 | English | Compare |
v8 | 2020-07-10 | French | Compare |
Showing 1 to 8 of 8